ZGNX News and Press, Zogenix Inc. From 01/21/22

Zogenix (NASDAQ: ZGNX) stock is having the ride of its life this week -- perhaps for the last time in its history. The biotech announced Wednesday it agreed to be acquired by Belgium-based pharmaceutical company UCB (OTC: UCBJF) . The deal is valued at up to $1.9 billion whe...

Here Are 5 Biotech Stocks To Check Out In The Stock Market Today As we move into the rest of 2022, it seems that biotech stocks could continue to be a viable play in the stock market. This can be attributed to the ongoing coronavirus concerns fueling the booming industry. Now, a...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Splash Beverage (NYSEAMERICAN: SBEV ) stock is soaring higher on Wednesday after the company revealed a new deal bringing its drinks to additional stores. Source: Abdul Razak Latif / Shutterstock.com This deal...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genius Sports (NYSE: GENI ) stock is on the rise Wednesday after an analyst initiated coverage of the sports data and tech company. Source: Karolis Kavolelis / Shutterstock.com Credit Suisse analyst Benjamin C...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Zogenix (NASDAQ: ZGNX ) stock is skyrocketing on Wednesday following news that UCB (OTCMKTS: UCBJY ) intends to acquire the company in a $1.9 billion deal. Source: Shutterstock.com The deal between the t...

MONSEY, N.Y., Jan. 19, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Zogenix, Inc. (Nasdaq: ZGNX) (“Zogenix”) acted in the best interests of ZGNX shareholders in approving the proposed acquisition of Zogenix by UCB, ...

Shares of the small-cap drugmaker Zogenix (NASDAQ: ZGNX) rose by as much as 67% in pre-market trading Wednesday morning. The company's shares are surging higher today in response to a buyout agreement with the Belgian pharmaceutical company UCB. UCB will reportedly pay $ 26 ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re diving right into trading today with the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com Moving stocks this morning are clinical trials, ear...

UCB to acquire Zogenix - Transaction broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy, complementing existing medicines and expanding clinical development pipeline of epilepsy and rare dise...

Zogenix (NASDAQ:ZGNX) has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour & Welfare (MHLW) for the marketing approval of Fintepla (fenfluramine) for the treatment of epileptic seizures associated with Dravet syndrome. The submission is supported by the re...